Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Operating Expenses | 17,148 | 14,358 | 15,021 | 11,562 | 10,590 |
| Operating Income | -17,148 | -14,358 | -15,021 | -11,562 | -10,590 |
| Other Income | 386 | 297 | 312 | 160 | 78 |
| Pre-tax Income | -16,762 | -14,061 | -14,709 | -11,402 | -10,512 |
| Net Income Continuous | -16,762 | -14,061 | -14,709 | -11,402 | -10,512 |
| Net Income | $-16,762 | $-14,061 | $-14,709 | $-11,402 | $-10,512 |
| EPS Basic Total Ops | -0.33 | -0.28 | -0.30 | -0.30 | -0.23 |
| EPS Basic Continuous Ops | -0.33 | -0.28 | -0.30 | -0.27 | -0.24 |
| EPS Diluted Total Ops | -0.33 | -0.28 | -0.30 | -0.30 | -0.23 |
| EPS Diluted Continuous Ops | -0.33 | -0.28 | -0.30 | -0.27 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -9,999.00 | -0.28 | -0.30 | -0.30 | -0.47 |
| EBITDA(a) | $-16,758 | $-14,186 | $-14,845 | $-11,350 | $-10,332 |